5 Best-Selling Orphan Drugs in the U.S.

Small is big when it comes to the biopharmaceutical industry. Orphan drugs target rare diseases and disorders that typically affect fewer than 200,000 people in the U.S. But while relatively few patients benefit from orphan drugs, the market size is very large because of the high price tags of the drugs.